Back HCV Disease Progression

HCV Disease Progression

ICAAC 2011: Interferon May Reduce Liver Disease Progression in HIV/HCV Coinfected Relapsers

Unsuccessful interferon-based therapy for chronic hepatitis C virus (HCV) infection appeared to improve or slow liver fibrosis progression in HIV/HCV coinfected people, but this was usually temporary, according to 2 studies presented the 51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2011) last month in Chicago.

Read more:

ICAAC 2011: Didanosine, Higher HCV Viral Load Predict Liver Fibrosis in HIV/HCV Coinfected People

Use of didanosine (ddI, Videx) -- along with higher hepatitis C virus (HCV) RNA level, male sex, and older age -- was a significant risk factor for liver fibrosis in people with HIV/HCV coinfection, researchers reported at the 51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2011) this week in Chicago.alt

Read more:

Gene Variation Linked to Liver Cancer in Hepatitis C Patients

A genome-wide association study looking at more than 460,000 single nucleotide changes found that a variation in the DEPDC5 gene on chromosome 22 is associated with increased risk of hepatocellular carcinoma in people with hepatitis C.

Read more:

HCV Can Be Sexually Transmitted Between HIV+ Men

Hepatitis C virus (HCV) is transmitted by sex between HIV positive gay/bisexual men and sexual transmission is responsible for several local epidemics, including one in New York City, according to study findings published recently in the CDC's Morbidity and Mortality Weekly Report.alt

Read more:

Caffeine and Liver Disease in People with Hepatitis C

Regularly consuming larger amounts of caffeine has a significant beneficial effect on liver inflammation, but not fibrosis, according to biopsy results from people with chronic hepatitis C. alt

Read more: